 |
 |

When and How Should the Patient With Dermatomyositis or Amyopathic Dermatomyositis Be Assessed for Possible Cancer?
Arch Dermatol. 2002;138:969-971.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
IN 1975 when I first became interested in the relationship between dermatomyositis
and cancer, the data were controversial about the existence of a relationship,
whether the relationship was unique for those patients with cutaneous disease
as opposed to the entire group of patients with inflammatory myopathy, and
the exact method that should be recommended for the discovery of malignancy.1-2 In the late 1970s and early 1980s,
the recommendations for the evaluation of the patient with dermatomyositis
(DM) or polymyositis (PM) varied widely, but in general we were taught that
on diagnosis the patient should undergo a "malignancy" workup that began with
a complete history and physical examination, "routine" laboratory tests (eg,
a complete blood count and serum multiphasic analysis), a sigmoidoscopic examination,
and radiographic studies including mammography screening, chest radiography,
upper gastrointestinal tract imaging, barium enema, and an intravenous pyelography.
Some authors went on to suggest that if no malignancy . . . [Full Text of this Article]
RELATED ARTICLE
Routine vs Extensive Malignancy Search for Adult Dermatomyositis and Polymyositis: A Study of 40 Patients
Agnès Sparsa, Eric Liozon, François Herrmann, Kim Ly, Valérie Lebrun, Pascale Soria, Véronique Loustaud-Ratti, Marie-Laure Bouyssou-Gauthier, Serge Boulinguez, Christophe Bédane, Marie-Odile Jauberteau, Elisabeth Vidal, and Jean-Marie Bonnetblanc
Arch Dermatol. 2002;138(7):885-890.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Tumor Antigen Markers for the Detection of Solid Cancers in Inflammatory Myopathies
Amoura et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1279-1282.
ABSTRACT
| FULL TEXT
A Helpful Clinical Sign Predictive of Cancer in Adult Dermatomyositis: Cutaneous Necrosis
Mahe et al.
Arch Dermatol 2003;139:539-539.
FULL TEXT
|